{
  "docId": "019dd923-5e88-73ef-bd5a-d62c891ad637",
  "docSlug": "d07ec288d5b21a01",
  "documentTitle": "2025 JP Morgan Healthcare Conference",
  "authorId": "JPMorgan",
  "authorName": "P&A Global",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "equity_research",
  "sourceTypeLabel": "Equity research",
  "presentationDate": null,
  "orientation": "portrait",
  "aspectRatio": 0.773,
  "pageNumber": 1,
  "pageCount": 3,
  "prevPage": null,
  "nextPage": 2,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide acts as a summary of industry updates from a specific conference.",
  "elementsJson": [
    "numbered_list",
    "logo_grid"
  ],
  "metadataConfidence": 0.95,
  "imagePath": "https://imgproxy.kitesheet.com/zAfZp1L-6MSOYLL99iB7E5PCVLqfphiZZU6JDdvH0gs/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kMDdlYzI4OGQ1YjIxYTAxL3AwMDEuanBn",
  "slideHref": "/slides/019dd923-5e88-73ef-bd5a-d62c891ad637/1",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5a-d62c891ad637",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5a-d62c891ad637.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-d62c891ad637#slide-1",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.15,
        "x": 0.03,
        "y": 0.02
      },
      "kind": "image",
      "text": "P&A Global Logo",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bd26ea90-60fd-4f34-9933-dda642005f25",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.75,
        "x": 0.148,
        "y": 0.27
      },
      "kind": "list",
      "text": "1. Alnylam Pharmaceuticals: Focused on RNAi technologies, Alnylam reported significant growth and pipeline advancements, including positive Phase III data for Amvuttra in treating ATTR-CM. The company aims for a 40% revenue CAGR through 2025 and plans to launch Amvuttra in the US, Japan, and Germany in 2025.\n2. BioMarin Pharmaceuticals: Celebrated revenue growth and outlined plans for expanding indications for Voxzogo and Palynziq. The company anticipates several top-line results in 2025 and aims to achieve large BioPharma peer profit margins by 2026.\n3. Bristol Myers Squibb: Highlighted double-digit sales growth and the success of new brands like Cobenfy. The company plans to focus on newer assets to counter the impact of generics and aims for significant cost savings and reinvestment in growth initiatives.\n4. Incyte: Reported revenue growth and regulatory submissions for several products. The company expects pivotal trial readouts and multiple product launches in 2025, positioning it for future growth.\n5. Moderna: Emphasized its mRNA platform and reported significant sales from Spikevax. The company anticipates regulatory approvals and late-stage pipeline milestones in 2025, including a new COVID-19 vaccine and a combination flu/COVID-19 vaccine.\n6. Neurocrine Biosciences: Focused on the success of Ingrezza and the recent launch of Crenessity. The company plans to invest heavily in RCD and aims to deliver a new medicine to the market every two years.",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a39436ad-f268-4f30-833e-c9eeccd47f41",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.51,
        "x": 0.148,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "Overview of Large, Mid and Small Pharmaceutical Companies",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "13adf552-a020-4632-a61f-df3f284778a3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.65,
        "x": 0.148,
        "y": 0.237
      },
      "kind": "paragraph",
      "text": "Day 1 Presentation on achievements, financial performance, and future plans.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d484e3c2-99d4-46b5-a8ea-f57176192161",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.41,
        "x": 0.148,
        "y": 0.163
      },
      "kind": "title",
      "text": "2025 J.P. Morgan Healthcare Conference",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1884fb77-632c-4397-8289-6d13bbb488b6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "2c0965f1-4458-464e-861e-c6ed51baf5d1",
      "evidence": "Day 1 Presentation on achievements, financial performance, and future plans.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 1,
      "from": 1,
      "beatId": "643c71f0-37f5-4157-bc1e-96c93b70d255",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Setup",
      "beatSlug": "setup",
      "evidence": "The executive summary likely sets up the context for the conference.",
      "position": 0,
      "confidence": 0.7,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": "https://imgproxy.kitesheet.com/HvievmTSubrD8YhlXUHAqOMY8u1RABzFIHNz6SgcpSE/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kMDdlYzI4OGQ1YjIxYTAxL3AwMDEucG5n",
  "thumbSrc": "https://imgproxy.kitesheet.com/I9a2Xy34KQHbF031gs3YDTVrK5buJ6DMGqDRkmilNrE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kMDdlYzI4OGQ1YjIxYTAxL3AwMDEuanBn",
  "thumbSrcAlt": "https://imgproxy.kitesheet.com/RX9YxOg2NCeJ8_yIn-CcABvkFu5d3Mmn4Px9OCtABns/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kMDdlYzI4OGQ1YjIxYTAxL3AwMDEucG5n"
}